Additional autoimmune neurological diseases targeted by pathogenic autoantibodies involve alpha-amino-3-hydroxy-5methyl-4-isoxazolepropionic receptor/AMPAR (GRIA1 and GRIA2) and channel scaffold proteins such as the secreted leucine rich glioma inactivated 1 protein (LGI1) and the neurexin family protein contactin associated protein 2 (CNTNAP2) (30). This evidence concerns the gene LGI1 and autoimmune disorder of the nervous system.